WallStreetZenWallStreetZen

NASDAQ: BGLC
Bionexus Gene Lab Revenue

OverviewEarningsRevenue
DividendOwnership
Bionexus Gene Lab revenue was $9.51M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $2.5M, down 4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BGLC annual revenue was $9.5M, with -2.7% growth year-over-year.

BGLC past revenue growth

How has BGLC's revenue growth performed historically?

Company
-2.66%
Industry
-0.68%
Market
20.27%
BGLC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BGLC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BGLC's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BGLC revenue history

Current Revenue
$9.5M
Current Earnings
-$1.6M
Current Profit Margin
-16.8%

Be the first to know when BGLC announces revenue.

BGLC Revenue History By Year

BGLC Yearly RevenueBGLC RevenueBGLC ChangeBGLC Revenue Growth
2024-12-31$9.51M-$260.16k-2.66%
2023-12-31$9.77M-$1.16M-10.60%
2022-12-31$10.93M-$2.43M-18.21%
2021-12-31$13.36M$1.97M+17.31%
2020-12-31$11.39M$11.26M+8,872.03%
2019-12-31$126.96k-$85.37k-40.21%
2018-12-31$212.33k$104.65k+97.18%
2017-12-31$107.68kN/AN/A

1 of 1

Bionexus Gene Lab Revenue FAQ

What was BGLC's revenue last quarter?

Bionexus Gene Lab (NASDAQ: BGLC) reported Q4 2024 revenue of $2.52 million up 11.03% year over year. In the same quarter last year, Bionexus Gene Lab's revenue was $2.27 million.

What was Bionexus Gene Lab's revenue in 2024?

Bionexus Gene Lab's annual revenue for the twelve months ending Dec 31, 2024 was $9.51 million, a 2.66% decrease year over year.

How much does Bionexus Gene Lab make in a day?

Based on Bionexus Gene Lab annual revenue for the past five years, BGLC makes an average of $30,116.80 per day.

What was Bionexus Gene Lab's annual revenue growth in the past year?

As of Q2 2025, Bionexus Gene Lab's revenue has grown -2.66% year over year. This is 1.99 percentage points lower than the US Specialty Chemicals industry revenue growth rate of -0.68%. Bionexus Gene Lab's revenue in the past year totaled $9.51 million.

How much does Bionexus Gene Lab make in a year?

Bionexus Gene Lab's revenue by year for the past five years is:
  • Bionexus Gene Lab's revenue for the twelve months ending Dec 31, 2024 was $9.51 million, a 2.66% decrease year over year.
  • Bionexus Gene Lab's annual revenue for Dec 31, 2023 was $9.77 million, a 10.6% decrease from 2022.
  • Bionexus Gene Lab's annual revenue for 2022 was $10.93 million, a 18.21% decrease from 2021.
  • Bionexus Gene Lab's annual revenue for 2021 was $13.36 million, a 17.31% increase from 2020.
  • Bionexus Gene Lab's annual revenue for 2020 was $11.39 million, a 8,872.03% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.